C2N Diagnostics, LLC

Biotechnology company · St. Louis, Missouri, United States

C2N Diagnostics, LLC is a biotechnology company headquartered in St. Louis, Missouri, United States. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $3.1 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2025.

www.c2ndiagnostics.comProfile compiled from public records. Is this your company? Request a correction or update

C2N Diagnostics at a glance

Typebiotechnology company

HeadquartersSt. Louis, Missouri, United States

Employees (self-reported, 2019)10

SEC CIK2021597

What does C2N Diagnostics do?

US government research funding

5 SBIR/STTR small-business research awards from US health agencies, $3.1 million in total (2009 to 2019). NIH funding came from the National Institute on Aging.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $10 million sold (2025).

Frequently asked questions about C2N Diagnostics

Where is C2N Diagnostics headquartered?

C2N Diagnostics, LLC is headquartered in St. Louis, Missouri, United States.

What does C2N Diagnostics do?

C2N Diagnostics, LLC is a biotechnology company.

Similar companies

MediBeacon Inc.St. Louis, Missouri, United States
Pulse Therapeutics, Inc.St. Louis, Missouri, United States
Panome Bio Inc.St. Louis, Missouri, United States
Cardialen, Inc.St. Louis, Missouri, United States
Gateway Biotechnology, Inc.St. Louis, Missouri, United States
Confluence Life Sciences, Inc.St. Louis, Missouri, United States
BacterioScan, Inc.St. Louis, Missouri, United States
Precision Virologics, Inc.St. Louis, Missouri, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-24. Data licences